MEGHAN GOLSON: Open Payments
NPI 1346774866 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$530 in 29 payments from 8 companies in 2025. Trend: 2023 $1,031 · 2024 $1,066 · 2025 $530
Food & beverage: $530
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 9 | $160 |
| Novo Nordisk Inc | 6 | $116 |
| Dexcom, Inc. | 5 | $88 |
| PFIZER INC. | 3 | $54 |
| Lilly USA, LLC | 3 | $51 |
| Abbott Laboratories | 1 | $24 |
| Amgen Inc. | 1 | $19 |
| Exact Sciences Corporation | 1 | $18 |
Products named: TRELEGY ELLIPTA, Dexcom G6 Transmitter, Ozempic, AREXVY, JARDIANCE, FREESTYLE LIBRE 3, Wegovy, KRYSTEXXA.
Industry payments across AL — which companies pay providers there.
